Morning Research on Valeant Pharma Intl., Hospira, Delcath Systems, and Alkermes

   Morning Research on Valeant Pharma Intl., Hospira, Delcath Systems, and
                                   Alkermes

PR Newswire

LONDON, March 11, 2013

LONDON, March 11, 2013 /PRNewswire/ --

The two biggest trends in the healthcare industry in the last one year have
been the Affordable Care Act (ACA) and the expiration of patents on several
blockbuster drugs. These trends are expected to have a major impact on drug
delivery companies such as Valeant Pharmaceuticals International Inc. (NYSE:
VRX), Hospira Inc. (NYSE: HSP), Delcath Systems Inc. (NASDAQ: DCTH) and
Alkermes Plc (NASDAQ: ALKS). While supporters of ACA state that the increase
in the number of insured individuals as a result of the reform will ultimately
benefit healthcare companies, critics on the other hand are saying that rising
costs due to ACA will hurt innovation as companies will have to scale back
research and development expenses. On Friday, healthcare stocks ended mostly
higher, tracking gains in the broad market. StockCall has posted free
technical research reports on VRX, HSP, DCTH, and ALKS and these can be
accessed by signing up at

http://www.stockcall.com/analysis

Shares of Valeant Pharmaceuticals International Inc. rose sharply in Friday's
trading session. The stock closed 1.35% higher at $70.78. It reached a 52-week
high of $70.85 in Friday's session. Valeant shares have had an excellent run
in 2013. Year-to-date, the stock has gained more than 18%. The stock recently
broke through $68 resistance level, which is a strong bullish signal. The
bullish trend is further confirmed by the recent volume activity and the MACD
chart. Download the free report on VRX upon registration at

http://www.StockCall.com/VRX031113.pdf

Shares of Hospira Inc. also rose sharply in Friday's trading session. The
stock closed 1.52% higher at $30.11, extending its gains in the last three
trading sessions to over 3%. Despite the recent gains, Hospira Inc. shares are
still down more than 3.60% for the year. The losses have been mainly due to a
sharp decline last month. The company's shares are currently trading well
below their 50-day and 200-day moving averages. However, the stock's MACD
chart suggests that the bearish trend has come to an end. The stock's MACD
recently crossed above the signal line. HSP technical report can be accessed
for free by signing up at

http://www.StockCall.com/HSP031113.pdf

Shares of Delcath Systems Inc. rallied in Friday's trading session. The stock
closed 4.26% higher at $1.96, extending its gains in the last three trading
sessions to nearly 16%. Delcath shares have had an excellent run in 2013,
gaining nearly 60%. The stock recently broke through $1.70 resistance level,
which is a strong bullish signal. The positive trend is further confirmed by
recent volume activity. The stock has finished higher in 9 of the previous 10
trading sessions. The stock's MACD is also trading above the signal line and
zero-line, further confirming the upbeat trend. The free report on DCTH can
be downloaded by signing up now at

http://www.StockCall.com/DCTH031113.pdf

Shares of Alkermes Plc also edged higher in Friday's trading session. The
stock closed 1.46% higher at $22.87. Year-to-date, the company's shares have
now gained nearly 23.50%. The stock has just broken through $22.50 resistance
level. It currently has strong support at around $22. The MACD chart for
Alkermes is giving strong bullish signals. The stock's MACD is trading well
above the signal line and the zero-line. The stock is also trading above its
50-day and 200-day moving averages. Free report on ALKS can be accessed by
registering at

http://www.StockCall.com/ALKS031113.pdf

About StockCall.com

StockCall.com is a financial website where investors can have easy, precise
and comprehensive research and opinions on stocks making the headlines. Sign
up today to talk to our financial analyst at

http://www.stockcall.com

SOURCE StockCall.com

Contact: Contact Person: William T. Knight, Email: info@stockcall.com, Contact
Number: +1(646)396-9857 (9:00 am EST – 01:30 pm EST)